NPC Member Spotlight: Reproductive Medicine Associates of New York

We’re exited to begin a new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to oncofertility@northwestern.edu.  If you are interested in learning more about how to join the NPC, contact Brigid Smith at brigid.smith@northwestern.edu or (312)503-2506.

*************************************************************************

RMANY

Reproductive Medicine Associates of New York

The Division of Reproductive Endocrinology & Infertility of Mount Sinai at Reproductive Medicine Associates of New York is committed to preserving the dream of family building for reproductive age men and women who are diagnosed with cancer.  Our oncofertility program has been established to work quickly and closely with oncologists to meet the needs of our patients.  All patients who request fertility preservation are seen within 48 hours of their call, and in many cases, patients can start fertility preservation treatment within days.

Although chemotherapy, radiation and surgery are lifesaving, the treatment may compromise sperm and egg function.  Our male and female fertility preservation programs are designed to cryopreserve eggs, embryos or sperm before reproductive cells are lost.

RMA of New York uses the most advanced freezing technology to preserve reproductive cells. Vitrification (ultra-rapid-freezing) of oocytes (eggs) and embryos results in extremely high survival rates of cells.   Once frozen, the reproductive cells can be stored indefinitely and can be saved until family building is desired.

The RMA of New York Oncofertility Center of Excellence provides expert quality care, offers patients concierge services, and integrates care with medical and surgical oncologists. Patients undergoing cancer treatment typically have to coordinate care with multiple medical specialists, but the fertility care should not be challenging.  RMA of New York physicians serve on the faculty of the Mount Sinai School of Medicine, and are involved in extensive clinical research to further the science and hopes of reproductive medicine.

For more information, visit www.rmany.com or call 212.756.5777 to speak with a dedicated oncofertility specialist.

Exciting Updates from the Portuguese Center for Fertility Preservation

The Oncofertility Consortium Global Partner, The Portuguese Centre for Fertility Preservation (Coimbra Hospital and University Centre), now has brand new facilities! 

PORTUGALBLOG3 (2)Last December, the Portuguese heath minister launched the new space for this Oncofertility Centre, to support cancer patients in the preservation of their fertility and other reproductive decisions. Prior to this centre opening, the Portuguese Centre for Fertility Preservation was based within the Reproductive Medicine Department of Coimbra Hospital and University Centre.

The opening of the new Oncofertility facility is an important achievement in Portugal. On one hand, it is an acknowledgement by the Portuguese government that this field of intervention is important and, on the other hand, it can be tailored to the specific follow-up and monitoring needed for oncofertility patients as compared to traditional infertile couples.

Information about cancer-related infertility and the fertility preservation needs to be provided to oncologists and patients, but also to the general population. Keeping this in mind, the team of the  Portuguese Centre for Fertility Preservation have created a video to disseminate the message of Oncofertility, drawing attention to its importance and impact in the young cancer patients’ lives.

Be sure to check out their “Information makes all the difference” educational video – English translation available here: http://youtu.be/4Mcv0xSygbA

NPC Member Spotlight: Fertility Associates of Memphis

We’re exited to begin a new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to oncofertility@northwestern.edu.  If you are interested in learning more about how to join the NPC, contact Brigid Smith at brigid.smith@northwestern.edu or (312)503-2506.

*************************************************************************

Screen Shot 2015-02-11 at 11.08.09 AMFertility Associates of Memphis

A major focus for our practice is to provide fertility preservation for those diagnosed with cancer. We offer patients struggling with cancer all options medically possible for the preservation and optimization of future fertility. These tools include in vitro fertilization with egg and embryo freezing, sperm freezing, radiation field minimizing surgery, and ovarian tissue freezing. Because this is a central part of our practice, we have considerable experience in all aspects of these technologies and work with some of the most respected institutions in the country, including St. Jude Children’s Research Hospital, to facilitate the best care for our patients.

Pediatric Fertility Preservation

As the functional Reproductive Endocrinology and Infertility division for St. Jude Children’s Research Hospital, we facilitate a wide range of fertility preservation strategies for children suffering with a cancer diagnosis. Our physicians all hold academic appointments at St. Jude and we conduct an onsite clinic in this facility to facilitate maximal accessibility. From our long established sperm freezing program for boys to our cutting edge egg freezing protocols for girls, we are helping children throughout our region and the world preserve hope for having family after cancer is a distant memory.

Adult Fertility Preservation

For the past several decades, Fertility Associates of Memphis has set the standard in the Mid-South region for offering the best available fertility preservation options for women and men with a cancer diagnosis. With the perfection and increased utilization of our egg freezing protocols, women with cancer are now routinely offered IVF with egg or embryo freezing prior to the initiation of chemotherapy or radiation, even in the setting of estrogen/progesterone positive breast cancer.

Our Physicians

Our physicians are experts in the field of Reproductive Endocrinology and Fertility, trained at some of the world’s most respected institutions including The Johns Hopkins University School of Medicine and Harvard University School of Medicine. In addition, our physicians regularly publish academic research give academic talks that help train other physicians from around the country and world how to best care for patients suffering with fertility related problems.

To make an appointment with any of the physicians at Fertility Associates of Memphis, please contact our office at 901-747-2229. We would be happy to help evaluate your fertility and explore steps you can take to maximize your chances of achieving pregnancy.

 

 

NPC Member Spotlight: Oregon Health & Science University

We’re exited to begin a new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to oncofertility@northwestern.edu.  If you are interested in learning more about how to join the NPC, contact Brigid Smith at brigid.smith@northwestern.edu or (312)503-2506.

*************************************************************************

Screen Shot 2015-02-03 at 9.36.02 AM

Oregon Health & Science University (OHSU) is a national leader in fertility patient care and research. The OHSU Fertility Consults provide a variety of options for cancer patients facing potential reproductive risks caused by their cancer therapy, including:

  • initial consultation
  • oocyte freezing
  • embryo banking
  • hormonal supression with Lupron
  • ovarian tissue banking
  • ovarian pexy for women and sperm banking (post-pubertal) for men

Consultations for hormonal management of bleeding during chemotherapy are also available. Learn more about oncofertility services at OHSU Fertility Consultants.

The OHSU Knight Cancer Institute Adolescent and Young Adult Oncology Program (AYA) offers services unique to young people undergoing cancer treatment, including fertility preservation, support groups and activities specific to ages 15-39. Learn more about how the AYA program supports fertility options.

The OHSU Division of Reproductive and Developmental Sciences (DRDS) at the Oregon National Primate Research Center (ONPRC) conducts basic and applied research on non-human primates (primarily macaque species) to increase our understanding of primate reproduction and embryonic/fetal development, and to use this knowledge to control reproductive disorders, fertility and neonatal health.

OHSU research training programs are available for individuals entering science-oriented careers (pre-and post-doctoral fellows) and a research-oriented knowledge base in primate reproduction and development for others (K-12, high school teachers, college undergraduates, and the local public) in collaboration with local programs.

DRDS serves as a regional, national and international resource, especially as it relates to NHP models and research.  Learn more about the OHSU ONPRC Division of Reproductive and Developmental Sciences.

NPC Member Spotlight: Children’s National Medical Center

We’re exited to begin a new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to oncofertility@northwestern.edu.  If you are interested in learning more about how to join the NPC, contact Brigid Smith at brigid.smith@northwestern.edu or (312)503-2506.

*************************************************************************

Screen Shot 2015-01-29 at 2.55.33 PM

Pediatric and Adolescent Gynecology

Children’s National is the only hospital in the Washington, DC, area participating in the Oncofertility Consortium, an interdisciplinary research network of doctors, scientists, and scholars with a shared goal to preserve fertility options for cancer survivors. We are one of the hospitals nationwide with an Institutional Review Board (IRB) approved process for ovarian tissue freezing (cryopreservation), an experimental fertility preservation option for young women.

Working closely with the Oncology team, the pediatric gynecology team offers full counseling for patients, educating and empowering families to make informed decisions about treatment. Children’s doctors explain the age-appropriate options for fertility preservation for girls and young women so we can help protect patient choices about starting a family in the future. We offer ovarian tissue freezing, gonadopexy (moving the ovaries away from the planned radiation field) as well as conservative surgery for ovarian and pelvic tumors.

Contact:

Veronica Gomez-Lobo, MD
Director of Pediatric and Adolescent Gynecology/Fertility Preservation Program for Young Girls
Veronica.gomez-lobo@medstar.net
202-877-4099

 

The Clinic for Adolescent and Adult Pediatric-Onset Urology (CAPITUL)

Through the Clinic for Adolescent and Adult Pediatric-Onset Urology (CAPITUL), headed by Dr. Michael Hsieh, Children’s National will soon be the only hospital in the Washington, DC, area participating in testicular tissue freezing (cryopreservation) as part of the Oncofertility Consortium. We will soon be  one of the few hospitals nationwide with an ethics board-approved process for testicular tissue freezing (cryopreservation), an experimental fertility preservation option for young men.

Working closely with the Oncology team, the CAPITUL team offers full counseling for patients, educating and empowering families to make informed decisions about treatment. Children’s doctors explain the age-appropriate options for fertility preservation so we can help protect patient choices about starting a family in the future. We will soon offer testicular tissue freezing for boys about to undergo chemotherapy and radiation therapy that may impact their fertility.

Contact:

Michael H. Hsieh, MD, PhD
Director, Clinic for Adolescent and Adult PedIatric OnseT UroLogy (CAPITUL), Children’s National Health System
mhsieh@cnmc.org
202-476-5042

 

 

NPC Member Spotlight: University of Pittsburgh

We’re exited to begin a new blog series to spotlight National Physicians Cooperative member institutions!  If your institution is a member of the NPC, submit your information to us for development of an institution-specific page on the Oncofertility Consortium website, as well as a blog post, to oncofertility@northwestern.edu.  If you are interested in learning more about how to join the NPC, contact Brigid Smith at brigid.smith@northwestern.edu or (312)503-2506.

*********************************************************************

Screen Shot 2015-01-29 at 8.12.52 AM

The Fertility Preservation Program of Pittsburgh was established at University of Pittsburgh Medical Center in 2009. Our multidisciplinary working group includes key stake holders at Magee-Womens Research InstituteMagee-Womens Hospital of UPMC and Children’s Hospital of Pittsburgh of UPMC. The program is committed to

  1. Educating patients and their physicians about the reproductive consequences of chemotherapy and radiation treatments for cancer or other conditions
  2. Providing state of the art reproductive technologies to preserve fertility for women, men, girls, and boys
  3. Responsibly translating new reproductive technologies from the laboratory to the clinic

We provide the following services for our patients:

Screen Shot 2015-01-29 at 8.12.59 AM

Please call our dedicated fertility preservation phone line at (412)641-7475 to speak to a nurse or visit our website to learn more about the options for preserving your fertility.

Contact Details:

Screen Shot 2015-01-29 at 8.21.56 AMKyle E. Orwig, PhD, Director, Fertility Preservation Program, Magee-Womens Hospital of UPMC, Magee-Womens Research Institute & Foundation

Email: orwigke@upmc.edu  

Screen Shot 2015-01-29 at 8.22.08 AMKathrin Gassei, PhD, Program Coordinator

Email: gasseik@upmc.edu
Phone: 412-641-2700

Julie Seifert, CRNP, Nurse Coordinator

Email: lenaja@upmc.edu
Phone: 412-641-7475

Screen Shot 2015-01-29 at 8.17.27 AMJoe Sanfilippo, MD, Director, Center for Fertility and Reproductive Endocrinology, Magee-Womens Hospital of UPMC 

 

Screen Shot 2015-01-29 at 8.17.37 AMPeter Shaw, MD, Director, Adolescent and Young Adult Oncology, Children’s Hospital of Pittsburgh of UPMC

 

Screen Shot 2015-01-29 at 8.17.48 AMScott Kauma, MD, Clinical Director, Fertility Preservation Program, Magee-Womens Hospital of UPMC

 

Screen Shot 2015-01-29 at 8.17.55 AMShweta Nayak, MD, Director of Outreach, Fertility Preservation Program, Magee-Womens Hospital of UPMC

 

Screen Shot 2015-01-29 at 8.18.01 AMGlenn Cannon, MD, Pediatric Urology, Children’s Hospital of Pittsburgh of UPMC

 

 

Website:  http://www.mwrif.org/220

 

 

Upcoming events with SHARE

Screen Shot 2015-01-20 at 1.03.34 PM

SHARE, a support group for women facing breast and ovarian cancer,  has some great free webinars coming up and all are invited to participate!

Metastatic Breast Cancer:  On Thursday, January 29, from 12:30 PM to 1:30 PM EST, Dr. Shari Goldfarb of Memorial Sloan-Kettering Cancer Center, will answer the question, “What’s New in the Treatment of Metastatic Breast Cancer?” She’ll describe how the research findings presented at last month’s San Antonio Breast Cancer Symposium  are relevant for people living with metastatic disease.

Sign up for this free webinar here:

http://bit.ly/MBCupdate2015

Coping with Cancer:  On Tuesday, February 3, from 6:00 PM to 7:30 PM EST, we present “Coping with Cancer: If Cancer is a Gift, What’s the Return Policy?” Cancer psychologist Dr. Mindy Greenstein explores the balancing act of coping with cancer.

Sign up for this free webinar here:

http://bit.ly/cancercoping

Memoir Writing for those affected by Cancer: This special two-part webinar is presented by Abigail Thomas, author of A Three Dog Life and Safekeeping.

Thomas will offer tips on writing your story and will include an assignment for the second session to get you started. She teaches writing workshops and leads the Memoir Group at Kingston ‘s Oncology Support Program of the HealthAlliance of the Hudson Valley.

All affected by breast or ovarian cancer (including caregivers) are welcome. SHARE presents this series in collaboration with the Metastatic Breast Cancer Network (MBCN).

Register for both dates of this free series below:

Tuesday, February 17, 1:30 PM – 2:30 PM EST

http://bit.ly/memoirpt1

Tuesday, February 24, 1:30 PM – 2:30 PM EST

http://bit.ly/memoirpt2

inviTRA: International Fertility Fair

Screen Shot 2014-11-21 at 1.03.21 PMLast month, Spain hosted the first assisted reproduction trade fair for patients, inviTRA. The best national and international clinics participated in the free event with exhibitors able to directly address patients during seminars.  Attendees received access to the associated magazine, Assisted Reproduction which has over 500,000 monthly readers and contains explanation of topics by specialists, a forum where patients can ask questions and share experiences, a directory of ART clinics, list of available discounts and resources, along with information about the inviTRA fair, including access to available articles.

Dr. Woodruff featured in Evidence-Based Oncology Journal

Dr. Woodruff was featured in a recent article in Evidence-Based Oncology. Read the article below:

Fertility Preservation in Young Cancer Patients

Published Online: November 17, 2014
Surabhi Dangi-Garimella, PhD

Advanced diagnostic tools and innovative treatment measures in cancer have increased cancer survival rates in the United States. Efforts by the various stakeholders in the drug development process—research scientists, the pharmaceutical industry, the FDA—resulted in the approval of 6 new anticancer agents over a 1-year period ending July 31, 2014, according to the 2014 Progress Report by the American Association for Cancer Research. Additionally, 5 previously approved agents were endorsed for alternate indications.1Along with increased incidence, there has been a significant increase in the number of cancer survivors. While the United States had an estimated 3 million survivors in 1971, that estimate is expected to reach about 14.5 million in 2014, with nearly 380,000 having been diagnosed as children or adolescents.1 One issue that plagues cancer survivors is quality of life, which could stem from either emotional or physical problems, or a combination of the two. Infertility is a major concern: irradiation of the testes or a regimen that includes chemotherapy, especially alkylating agents, can reduce fertility.

To read the rest of the article, please click here.

17th Annual Oncology Nursing Conference

Screen Shot 2014-11-17 at 9.40.28 AM

This Friday and Saturday, November 21-22, 2014, marks the 17th Annual Oncology Nursing Conference which will be hosted by the Robert H. Lurie Comprehensive Cancer Center.  This year’s meeting, Survivorship: From Diagnosis and Beyond, will tackle important topics facing cancer survivors; from neurotoxicity to psychosocial distress to fertility, and everything in between.  The Fertility and Cancer presentation will be given by Northwestern’s very own Fertility Preservation Patient Navigator, Kristin Smith.

If you haven’t already done so, REGISTER NOW to reserve your spot at this exciting and educational event!

Page 1 of 5612345...102030...Last »
 
© Oncofertility Consortium Blog